TEVA and VTRS Related Headlines

Go Back

Jun 6, 2025 01:16PM Goldman Sachs initiates coverage on generic drugmakers, sees upside in Teva and Am

TEVA and VTRS Related Press Releases

Go Back

TEVA and VTRS Related SEC Filings

Go Back